Helios Kliniken Berlin Buch Gmbh

Berlin 13125

1 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Smoldering Multiple Myeloma

Studies at this site

• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
• A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma — Completed